Aarti Historical Balance Sheet

AARTIDRUGS

380.05 8.05 2.07%

Trend analysis of Aarti Drugs Limited balance sheet accounts such as Short Long Term Debt Total of 4.3 B, Other Current Liabilities of 255.7 M or Total Current Liabilities of 5 B provides information on Aarti Drugs' total assets, liabilities, and equity, which is the actual value of Aarti Drugs Limited to its prevalent stockholders. By breaking down trends over time using Aarti Drugs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Aarti Drugs Limited latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aarti Drugs Limited is a good buy for the upcoming year.

Aarti Drugs Inventory

5.87 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Aarti Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Aarti Drugs Limited at a specified time, usually calculated after every quarter, six months, or one year. Aarti Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aarti Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aarti currently owns. An asset can also be divided into two categories, current and non-current.

Aarti Drugs Balance Sheet Chart

At this time, Aarti Drugs' Other Stockholder Equity is relatively stable compared to the past year. As of 02/25/2025, Total Current Assets is likely to grow to about 15.9 B, while Other Current Liabilities is likely to drop slightly above 255.7 M.

Total Assets Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Aarti Drugs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aarti Drugs Limited books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Aarti Drugs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Aarti Drugs Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Aarti Drugs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Aarti Drugs Limited current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	6.1B	5.6B	6.5B	4.3B
Total Assets	24.2B	24.3B	28.0B	29.4B

Short Long Term Debt Total Total Assets

Aarti Drugs balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Current Deferred Revenue	Retained Earnings	Other Assets	Short Term Debt	Intangible Assets
Total Assets		0.71	0.11	0.79	0.99	0.98	0.7	0.51	0.98	0.01	0.63	0.83	-0.78	0.7	0.98	-0.04	-0.1	0.83	0.99	0.93	0.88	0.06	0.99	0.17	0.53	0.57
Short Long Term Debt Total	0.71		-0.15	0.88	0.63	0.71	1.0	0.31	0.71	0.02	0.48	0.78	-0.29	0.73	0.66	-0.08	-0.03	0.91	0.7	0.55	0.79	0.12	0.62	0.29	0.72	0.23
Other Current Liab	0.11	-0.15		-0.08	0.16	0.15	-0.14	-0.33	0.15	-0.18	-0.13	0.09	-0.17	0.3	0.09	-0.15	-0.29	0.03	0.08	0.09	0.12	-0.32	0.19	0.11	-0.42	0.25
Total Current Liabilities	0.79	0.88	-0.08		0.74	0.71	0.87	0.6	0.72	-0.03	0.73	0.95	-0.28	0.61	0.81	0.01	-0.11	0.97	0.82	0.7	0.94	0.25	0.71	0.29	0.65	0.12
Total Stockholder Equity	0.99	0.63	0.16	0.74		0.97	0.62	0.52	0.97	0.06	0.64	0.81	-0.81	0.66	0.98	0.0	-0.06	0.78	0.98	0.96	0.87	0.0	1.0	0.16	0.47	0.63
Property Plant And Equipment Net	0.98	0.71	0.15	0.71	0.97		0.71	0.37	1.0	0.0	0.48	0.75	-0.82	0.75	0.94	-0.07	-0.1	0.79	0.94	0.88	0.82	-0.01	0.97	0.11	0.46	0.67
Net Debt	0.7	1.0	-0.14	0.87	0.62	0.71		0.27	0.7	0.01	0.45	0.76	-0.28	0.73	0.65	-0.08	-0.02	0.9	0.68	0.53	0.77	0.1	0.61	0.29	0.71	0.23
Cash	0.51	0.31	-0.33	0.6	0.52	0.37	0.27		0.38	0.07	0.86	0.64	-0.25	0.18	0.62	-0.09	-0.03	0.53	0.6	0.61	0.65	0.54	0.5	0.03	0.49	-0.03
Non Current Assets Total	0.98	0.71	0.15	0.72	0.97	1.0	0.7	0.38		0.01	0.49	0.75	-0.83	0.74	0.94	-0.05	-0.1	0.78	0.94	0.88	0.82	-0.01	0.97	0.1	0.47	0.68
Non Currrent Assets Other	0.01	0.02	-0.18	-0.03	0.06	0.0	0.01	0.07	0.01		0.13	-0.14	-0.06	-0.29	0.05	0.28	0.93	-0.11	0.02	0.24	-0.03	-0.52	0.04	0.17	0.4	0.21
Cash And Short Term Investments	0.63	0.48	-0.13	0.73	0.64	0.48	0.45	0.86	0.49	0.13		0.8	-0.28	0.29	0.72	-0.04	0.0	0.66	0.72	0.71	0.78	0.34	0.61	0.42	0.66	0.0
Net Receivables	0.83	0.78	0.09	0.95	0.81	0.75	0.76	0.64	0.75	-0.14	0.8		-0.37	0.68	0.85	-0.02	-0.24	0.95	0.87	0.77	0.98	0.24	0.79	0.32	0.53	0.19
Common Stock Shares Outstanding	-0.78	-0.29	-0.17	-0.28	-0.81	-0.82	-0.28	-0.25	-0.83	-0.06	-0.28	-0.37		-0.48	-0.74	0.01	0.06	-0.36	-0.73	-0.73	-0.47	0.07	-0.83	0.11	-0.27	-0.79
Non Current Liabilities Total	0.7	0.73	0.3	0.61	0.66	0.75	0.73	0.18	0.74	-0.29	0.29	0.68	-0.48		0.65	-0.35	-0.33	0.78	0.65	0.55	0.72	0.09	0.69	0.13	0.26	0.39
Inventory	0.98	0.66	0.09	0.81	0.98	0.94	0.65	0.62	0.94	0.05	0.72	0.85	-0.74	0.65		-0.02	-0.07	0.83	0.99	0.95	0.91	0.11	0.97	0.19	0.53	0.49
Other Current Assets	-0.04	-0.08	-0.15	0.01	0.0	-0.07	-0.08	-0.09	-0.05	0.28	-0.04	-0.02	0.01	-0.35	-0.02		0.32	-0.09	-0.03	0.01	-0.04	-0.11	-0.01	-0.14	-0.05	0.26
Other Stockholder Equity	-0.1	-0.03	-0.29	-0.11	-0.06	-0.1	-0.02	-0.03	-0.1	0.93	0.0	-0.24	0.06	-0.33	-0.07	0.32		-0.19	-0.1	0.11	-0.14	-0.46	-0.09	0.22	0.29	0.11
Total Liab	0.83	0.91	0.03	0.97	0.78	0.79	0.9	0.53	0.78	-0.11	0.66	0.95	-0.36	0.78	0.83	-0.09	-0.19		0.84	0.71	0.96	0.22	0.77	0.27	0.6	0.21
Total Current Assets	0.99	0.7	0.08	0.82	0.98	0.94	0.68	0.6	0.94	0.02	0.72	0.87	-0.73	0.65	0.99	-0.03	-0.1	0.84		0.94	0.91	0.11	0.97	0.22	0.56	0.48
Common Stock	0.93	0.55	0.09	0.7	0.96	0.88	0.53	0.61	0.88	0.24	0.71	0.77	-0.73	0.55	0.95	0.01	0.11	0.71	0.94		0.83	-0.08	0.94	0.22	0.48	0.54
Accounts Payable	0.88	0.79	0.12	0.94	0.87	0.82	0.77	0.65	0.82	-0.03	0.78	0.98	-0.47	0.72	0.91	-0.04	-0.14	0.96	0.91	0.83		0.21	0.85	0.26	0.56	0.3
Current Deferred Revenue	0.06	0.12	-0.32	0.25	0.0	-0.01	0.1	0.54	-0.01	-0.52	0.34	0.24	0.07	0.09	0.11	-0.11	-0.46	0.22	0.11	-0.08	0.21		0.01	-0.23	0.14	-0.25
Retained Earnings	0.99	0.62	0.19	0.71	1.0	0.97	0.61	0.5	0.97	0.04	0.61	0.79	-0.83	0.69	0.97	-0.01	-0.09	0.77	0.97	0.94	0.85	0.01		0.13	0.45	0.66
Other Assets	0.17	0.29	0.11	0.29	0.16	0.11	0.29	0.03	0.1	0.17	0.42	0.32	0.11	0.13	0.19	-0.14	0.22	0.27	0.22	0.22	0.26	-0.23	0.13		0.32	-0.32
Short Term Debt	0.53	0.72	-0.42	0.65	0.47	0.46	0.71	0.49	0.47	0.4	0.66	0.53	-0.27	0.26	0.53	-0.05	0.29	0.6	0.56	0.48	0.56	0.14	0.45	0.32		0.1
Intangible Assets	0.57	0.23	0.25	0.12	0.63	0.67	0.23	-0.03	0.68	0.21	0.0	0.19	-0.79	0.39	0.49	0.26	0.11	0.21	0.48	0.54	0.3	-0.25	0.66	-0.32	0.1

Click cells to compare fundamentals

Aarti Drugs Account Relationship Matchups

Aarti Drugs balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	17.7B	22.1B	24.2B	24.3B	28.0B	29.4B
Short Long Term Debt Total	3.5B	5.4B	6.1B	5.6B	6.5B	4.3B
Other Current Liab	521.7M	(435M)	445.2M	567.2M	510.5M	255.7M
Total Current Liabilities	6.0B	9.4B	9.3B	8.0B	9.1B	5.0B
Total Stockholder Equity	9.1B	10.4B	11.9B	12.8B	14.7B	15.5B
Property Plant And Equipment Net	6.8B	7.7B	8.9B	10.5B	12.1B	12.7B
Net Debt	3.4B	5.2B	6.0B	5.6B	6.4B	4.2B
Cash	88.1M	216.1M	89.6M	67.4M	77.5M	65.7M
Non Current Assets Total	7.1B	8.1B	9.3B	11.1B	12.8B	13.4B
Non Currrent Assets Other	72.6M	284.4M	236.7M	9.0M	8.1M	8.5M
Cash And Short Term Investments	88.1M	216.1M	211.7M	89.3M	102.7M	74.5M
Net Receivables	5.6B	7.6B	8.6B	7.0B	8.1B	4.1B
Liabilities And Stockholders Equity	17.7B	22.1B	24.2B	24.3B	28.0B	29.4B
Non Current Liabilities Total	2.6B	2.3B	3.0B	3.5B	4.1B	2.6B
Inventory	4.2B	5.3B	5.2B	4.9B	5.6B	5.9B
Other Current Assets	645.8M	825.6M	900.5M	1.2B	1.4B	863.3M
Other Stockholder Equity	664.3M	650.1M	(47.0K)	15K	13.5K	14.2K
Total Liab	8.5B	11.7B	12.3B	11.5B	13.2B	7.6B
Total Current Assets	10.6B	13.9B	14.9B	13.2B	15.2B	15.9B
Accumulated Other Comprehensive Income	664.3M	650.1M	793.0M	343.7M	395.2M	415.0M
Common Stock	233M	932M	926M	919.4M	1.1B	1.1B
Accounts Payable	3.3B	4.7B	4.8B	4.5B	5.2B	2.8B
Current Deferred Revenue	(396.1M)	1.1B	43.7M	11.8M	13.6M	12.9M
Retained Earnings	7.5B	8.8B	10.2B	11.6B	13.3B	13.9B
Other Assets	11.5M	1K	72.6M	236.7M	1.15	1.09
Short Term Debt	2.0B	4.0B	4.0B	2.9B	3.3B	3.1B
Intangible Assets	2.6M	1.5M	7.9M	368.2M	423.5M	444.7M
Short Term Investments	127.2M	126.4M	122.1M	21.9M	25.1M	23.9M
Other Liab	1.1B	1.1B	912.2M	906.7M	1.0B	949.0M
Net Tangible Assets	6.5B	9.1B	10.4B	11.9B	13.7B	14.4B
Long Term Debt	1.5B	1.4B	2.0B	2.8B	3.2B	2.0B
Short Long Term Debt	1.6B	4.0B	4.0B	2.9B	3.3B	2.8B
Property Plant Equipment	6.5B	6.8B	7.7B	8.9B	10.2B	6.8B
Long Term Debt Total	1.9B	1.5B	1.4B	2.1B	1.8B	1.5B
Non Current Liabilities Other	(32K)	(3K)	(33K)	(58K)	(52.2K)	(49.6K)
Net Invested Capital	12.2B	15.7B	18.0B	18.4B	21.2B	15.0B
Net Working Capital	4.6B	4.5B	5.6B	5.3B	6.0B	4.1B
Capital Stock	233M	932M	926M	919.4M	1.1B	764.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Aarti Stock Analysis

When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC